Perez-Paramo Y, Watson C, Chen G, Thomas C, Adams-Haduch J, Wang R
Cancer Epidemiol Biomarkers Prev. 2022; 32(1):54-65.
PMID: 36252563
PMC: 9827107.
DOI: 10.1158/1055-9965.EPI-22-0868.
Schelstraete W, De Clerck L, Govaert E, Millecam J, Devreese M, Deforce D
Sci Rep. 2019; 9(1):9233.
PMID: 31239454
PMC: 6592956.
DOI: 10.1038/s41598-019-45212-0.
Arendse L, Blackburn J
Sci Rep. 2018; 8(1):11876.
PMID: 30089838
PMC: 6082832.
DOI: 10.1038/s41598-018-30195-1.
Lopez-Flores L, Perez-Rubio G, Falfan-Valencia R
EXCLI J. 2017; 16:174-196.
PMID: 28507465
PMC: 5427481.
DOI: 10.17179/excli2016-847.
Phompradit P, Muhamad P, Cheoymang A, Na-Bangchang K
Am J Trop Med Hyg. 2014; 91(2):361-6.
PMID: 24891466
PMC: 4125263.
DOI: 10.4269/ajtmh.13-0531.
Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer.
Yang L, Yang Y, Qin Q, Zhou A, Zhao J, Wang J
Mol Clin Oncol. 2014; 2(1):93-98.
PMID: 24649314
PMC: 3915807.
DOI: 10.3892/mco.2013.191.
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.
McDonagh E, Wassenaar C, David S, Tyndale R, Altman R, Whirl-Carrillo M
Pharmacogenet Genomics. 2012; 22(9):695-708.
PMID: 22547082
PMC: 3413746.
DOI: 10.1097/FPC.0b013e3283540217.
Genetic polymorphisms ofCYP2A6 andCYP2E1 with tobacco smoking is not associated with risk of urothelial cancer.
Tsukino H, Kuroda Y, Nakao H, Imai H, Osada Y, Inatomi H
Environ Health Prev Med. 2011; 7(3):129-31.
PMID: 21432295
PMC: 2723495.
DOI: 10.1265/ehpm.2002.129.
Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.
Ueng Y, Chen C, Chung Y, Liu T, Chang Y, Lo W
Br J Pharmacol. 2011; 163(6):1250-62.
PMID: 21418183
PMC: 3144538.
DOI: 10.1111/j.1476-5381.2011.01341.x.
Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T, David S, Tyndale R, Wang H, Zhou Q, Ding P
Addiction. 2011; 106(5):985-94.
PMID: 21205058
PMC: 3074015.
DOI: 10.1111/j.1360-0443.2010.03353.x.
A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.
Al Koudsi N, Ahluwalia J, Lin S, Sellers E, Tyndale R
Pharmacogenomics J. 2009; 9(4):274-82.
PMID: 19365400
PMC: 2922203.
DOI: 10.1038/tpj.2009.11.
CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.
Mahavorasirikul W, Tassaneeyakul W, Satarug S, Reungweerayut R, Na-Bangchang C, Na-Bangchang K
Eur J Clin Pharmacol. 2008; 65(4):377-84.
PMID: 19082995
DOI: 10.1007/s00228-008-0595-2.
Pharmacogenetics in psychiatry: are we ready for widespread clinical use?.
Arranz M, Kapur S
Schizophr Bull. 2008; 34(6):1130-44.
PMID: 18753306
PMC: 2632495.
DOI: 10.1093/schbul/sbn114.
Interindividual variability of methadone response: impact of genetic polymorphism.
Li Y, Kantelip J, Gerritsen-van Schieveen P, Davani S
Mol Diagn Ther. 2008; 12(2):109-24.
PMID: 18422375
DOI: 10.1007/BF03256276.
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1.
Fujita K, Yamamoto W, Endo S, Endo H, Nagashima F, Ichikawa W
Cancer Sci. 2008; 99(5):1049-54.
PMID: 18380793
PMC: 11158323.
DOI: 10.1111/j.1349-7006.2008.00773.x.
High prevalence of cytochrome P450 2A6*1A alleles in a black African population of Ghana.
Gyamfi M, Fujieda M, Kiyotani K, Yamazaki H, Kamataki T
Eur J Clin Pharmacol. 2005; 60(12):855-7.
PMID: 15660270
DOI: 10.1007/s00228-004-0854-9.
Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.
Saito S, Iida A, Sekine A, Kawauchi S, Higuchi S, Ogawa C
J Hum Genet. 2003; 48(5):249-270.
PMID: 12721789
DOI: 10.1007/s10038-003-0021-7.
Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.
Yoshida R, Nakajima M, Watanabe Y, Kwon J, Yokoi T
Br J Clin Pharmacol. 2002; 54(5):511-7.
PMID: 12445030
PMC: 1874463.
DOI: 10.1046/j.1365-2125.2002.01667.x.